US Stock MarketDetailed Quotes

VTAK Catheter Precision

Watchlist

0.376
+0.027+7.58%

Close Jul 3 13:00 ET

0.392
+0.016+4.28%

Post 15:15 ET

2.85MMarket Cap0.03P/E (TTM)

Catheter Precision Stock Forum

Trytosaveabit

Jun 17 07:47

Update

$Catheter Precision(VTAK.US)$ Catheter Precision, Inc. Announces Receipt of LockeT Purchase Order for Eisenhower Medical Center, a Third California Hospital
Accesswire· 2 mins ago

Trytosaveabit

May 13 07:32

Numbers please! Like though! Hehehe

$Catheter Precision(VTAK.US)$ Benzinga· 1 min ago
Catheter Precision, Inc. Secures Initial Orders For LockeT From Ronald Reagan UCLA Medical Center And Rady Children's Hospital In San Diego

Trytosaveabit

Apr 24 10:23

$Catheter Precision(VTAK.US)$ Spread a bit wide! Volume low! But up is up! Especially when the overall market is RED

Trytosaveabit

Apr 24 07:34

Update

$Catheter Precision(VTAK.US)$ Catheter Precision Receives First Purchase Order For LockeT From HCA Healthcare Facility

Trytosaveabit

Jan 24 16:08

Insider buy

$Catheter Precision(VTAK.US)$ Officer JENKINS DAVID A purchased 19,056 shares of Common Stocks on Jan 22, 23, 2024 at an average price of $0.5136 for a total value of $9,786.21.

Trytosaveabit

Jan 22 07:15

A bit more

$Catheter Precision(VTAK.US)$ Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Sequire Investor Summit in Puerto Rico

Trytosaveabit

Jan 22 07:10

Update

$Catheter Precision(VTAK.US)$ Catheter Precision, Inc. (VTAK) Secures New Distributor in Brazil for LockeT
ACCESSWIRE 22-Jan-2024

Trytosaveabit

Jan 17 07:07

$Catheter Precision(VTAK.US)$ Catheter Precision Announces Its VIVO System Was Highlighted In A Case Study In EP Lab Digest

Trytosaveabit

Jan 2 07:04

News

$Catheter Precision(VTAK.US)$ Catheter Precision, Inc Receives Additional Patents for LockeT in Great Britain and the European Market
Benzinga· 1 min ago

Trytosaveabit

Oct 12, 2023 07:09

News!

$Catheter Precision(VTAK.US)$ Catheter Precision's VIVO Is Now Eligible for National Reimbursement in the UK

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall